The establishment of Nihon Biobase was done within a very strict time frame of only three months. The new office, located in Shin Yokohama within the new Nisso 16 building, will coordinate the activities of its distributors and establish a new brand of biomarker discovery for both the therapeutic and diagnostic markets. These activities will be launched together with Biobase’s cooperation partners in Japan, mainly Tokyo University and GNI Limited.
Edgar Wingender, president of Biobase Germany and Nihon Biobase, said: “This new technology as service is tailored for the Japanese market, and we will undertake all efforts to serve the specific needs of our Japanese customers.”